Otsuka Pharma Scandinavia AB: public contracts won without a rival in Denmark: 3 uncontested awards; 43% of its awards; 1 without a competition; 2 single bid.
Assay record ASY-DK-09RJEP30XN · Cite as: Assay Systems, “Otsuka Pharma Scandinavia AB: public contracts won without a rival in Denmark”, https://assay-systems.com/register/dk/uncontested/s/otsuka-pharma-scandinavia-ab/
Otsuka Pharma Scandinavia AB won 3 of its 7 public contract awards in Denmark without a rival from 2024-10-28 to 2026-09-10: 1 without a competition and 2 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Amgros I/S with 3.
An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.
Amgros I/S gave Otsuka Pharma Scandinavia AB 7 awards: 1 without a competition, 2 after a competition with a single bid. First 2024-10-28, latest 2026-09-10.
| Date | Buyer | How | Stated reason |
|---|---|---|---|
| 2026-09-10 | Amgros I/S 624051-2026 | Single bid open | — |
| 2026-05-06 | Amgros I/S 309577-2026 | No competition neg-wo-call | technical |
| 2026-02-12 | Amgros I/S 100829-2026 | Single bid open | — |
Every uncontested award in Denmark · All countries · Otsuka Pharma Scandinavia AB in the register
Source: Tenders Electronic Daily (TED), Publications Office of the European Union, contract award notices. Awards are matched to their buyer and supplier as published. Values in these notices often state a framework ceiling rather than a contract amount, so awards are counted, not summed. Updated 17 October 2026.